GLP-1 Agonists
Orforglipron (Foundayo): The Oral GLP-1 Pill That Could Change Everything
Something historic happened in the GLP-1 space on April 1, 2026: the FDA approved the first oral GLP-1 pill with no food or water restrictions. Orforglipron (brand name Foundayo), developed by Eli Lilly, is not just another entry in a crowded drug class — it may be the breakthrough that finally